Urothelial Cancer Therapies
Feb 24, 2023
A Quick Recap from ASCO GU 2023: Prostate and Urothelial Cancer Highlights
The ASCO Genitourinary (GU) Cancers Symposium, which ended on February 18, 2023, was a three-day scientific and educational meeting designed to provide attendees with in-depth, multidisciplinary analysis of the timely topics in the study, diagnosis, and treatment of GU malignancies. DelveInsight has compiled the sy...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
